跳至主要内容
临床试验/CTRI/2023/03/050982
CTRI/2023/03/050982已完成Unknown

A comprehensive study of Serum Irisin and AMH in PCOS patients, its correlation with hormonal profile and markers of insulin resistance including change of irisin with metformin therapy - IRISIN IN PCOS

TELAGAREDDY RADHA KRISHNA0 个研究点目标入组 77 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
77

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Confirmed cases of PCOS
  • 2. Age 18â??40 years
  • 3. All PCOS women who did not receive oral contraceptives,
  • insulin-sensitizing agents, antiandrogens, or glucocorticoids in the past 3 months.
  • 4. Age and sex matched healthy adults are included in control group

排除标准

  • 1. Other causes for hyperandrogenemia and ovulatory dysfunction including
  • a. 21-alpha hydroxylase deficiency,
  • b. Congenital adrenal hyperplasia, and
  • c. Cushingâ??s syndrome
  • 4. Smokers.
  • 5. Alcoholics.
  • 6. Medicines that affect glucose/lipids/androgen metabolism within past 3 months.

研究者

发起方
TELAGAREDDY RADHA KRISHNA

相似试验

Irisin in PCOS and its change with metformin therapy. | 临床试验